German Giant Company Joins Bitcoin Whales: Will Hold Until 2027! - Coin Bulletin

robot
Abstract generation in progress

Germany-based biopharmaceutical company atai Life Sciences (ATAI) announced that it will invest in Bitcoin (BTC).

atai Life Sciences has turned to Bitcoin investments to enhance the financial sustainability of the company and optimize its capital. The company's Chairman of the Board, Christian Angermayer, asked in a statement on the Substack platform, "Can investing in bitcoin during a period of continuous inflation and volatile markets help preserve and optimize the capital held by biotechnology companies, thereby extending the company's duration and increasing its success?"

In the first phase, the company will receive $5 million worth of BTC. Angermayer said they will hold cash, short-term securities and publicly traded stocks required for operational expenses until 2027. With this step, atai Life Sciences is among the companies that follow Michael Saylor's Bitcoin treasury strategy.

The Bitcoin price briefly exceeded 87,000 dollars after this news, and is currently trading at around approximately 83,900 dollars.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments